InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 MillionGlobeNewsWire · Sep 21, 2026
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire · Sep 4, 2026
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewsWire · Sep 3, 2026
InspireMD (NSPR) Upgraded to Buy: Here's What You Should KnowZacks Investment Research · Aug 20, 2026
InspireMD, Inc. (NSPR) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 17, 2026
InspireMD Reports Second Quarter 2026 Financial ResultsGlobeNewsWire · Aug 17, 2026InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroNet stent platform technology, engineered to address various vascular and coronary diseases. The company's offerings, distributed through a network of local partners, reach markets across Europe, Latin America, the Middle East, and Asia Pacific.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 17, 2026 | -$0.20 | -$0.17 | Beat |
| May 4, 2026 | -$0.19 | -$0.16 | Beat |
| Mar 18, 2026 | -$0.22 | -$0.14 | Beat |
| Nov 4, 2025 | -$0.17 | -$0.17 | Beat |
| Aug 4, 2025 | -$0.24 | -$0.26 | Miss |
| May 9, 2025 | -$0.17 | -$0.22 | Miss |